|
| | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane Basic information |
| Product Name: | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane | | Synonyms: | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane;tert-Butyl 3-oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylate;3-Oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylic acid, 1,1-dimethylethyl ester;Racemic-(1R,5S)-tert-butyl3-oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylate | | CAS: | 1251010-45-3 | | MF: | C11H20N2O3 | | MW: | 228.29 | | EINECS: | | | Product Categories: | | | Mol File: | 1251010-45-3.mol | ![9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane Structure](CAS/20150408/GIF/1251010-45-3.gif) |
| | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane Chemical Properties |
| Boiling point | 325.8±42.0 °C(Predicted) | | density | 1.108±0.06 g/cm3(Predicted) | | storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C | | pka | 8.84±0.20(Predicted) |
| | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane Usage And Synthesis |
| Uses | tert-Butyl 3-oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylate is used in preparation of substituted pyrazolopyridines as inhibitors of FGFR tyrosine kinases for treatment of FGFRs-mediated diseases. |
| | 9-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane Preparation Products And Raw materials |
|
